Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$1.5 - $3.41 $60 - $136
-40 Reduced 0.22%
18,028 $45,000
Q3 2023

Nov 08, 2023

BUY
$3.17 - $7.91 $190 - $474
60 Added 0.33%
18,068 $61,000
Q2 2023

Aug 11, 2023

SELL
$7.35 - $13.21 $147 - $264
-20 Reduced 0.11%
18,008 $132,000
Q4 2021

Feb 08, 2022

SELL
$33.11 - $55.01 $4,502 - $7,481
-136 Reduced 0.75%
18,028 $784,000
Q3 2021

Nov 08, 2021

BUY
$50.07 - $66.05 $30,042 - $39,630
600 Added 3.42%
18,164 $909,000
Q2 2021

Aug 10, 2021

BUY
$56.61 - $80.46 $73,366 - $104,276
1,296 Added 7.97%
17,564 $1.11 Million
Q1 2021

May 10, 2021

SELL
$86.23 - $125.19 $1.81 Million - $2.62 Million
-20,958 Reduced 56.3%
16,268 $1.51 Million
Q4 2020

Feb 08, 2021

SELL
$79.17 - $111.47 $235,926 - $332,180
-2,980 Reduced 7.41%
37,226 $3.34 Million
Q3 2020

Nov 09, 2020

BUY
$81.91 - $134.94 $1.52 Million - $2.5 Million
18,508 Added 85.3%
40,206 $4.15 Million
Q2 2020

Aug 07, 2020

SELL
$54.33 - $89.52 $9,236 - $15,218
-170 Reduced 0.78%
21,698 $1.72 Million
Q4 2019

Feb 03, 2020

SELL
$51.21 - $59.06 $28,165 - $32,483
-550 Reduced 2.45%
21,868 $1.18 Million
Q2 2019

Aug 05, 2019

BUY
$39.92 - $53.86 $5,588 - $7,540
140 Added 0.63%
22,418 $1.08 Million
Q1 2019

May 03, 2019

SELL
$48.23 - $66.16 $354,345 - $486,077
-7,347 Reduced 24.8%
22,278 $1.13 Million
Q4 2018

Feb 01, 2019

BUY
$55.63 - $73.24 $415,945 - $547,615
7,477 Added 33.76%
29,625 $1.76 Million
Q3 2018

Oct 31, 2018

BUY
$52.05 - $66.51 $6,766 - $8,646
130 Added 0.59%
22,148 $1.46 Million
Q2 2018

Aug 06, 2018

SELL
$48.33 - $55.64 $1.37 Million - $1.58 Million
-28,450 Reduced 56.37%
22,018 $1.11 Million
Q1 2018

May 04, 2018

BUY
$44.44 - $54.39 $503,238 - $615,912
11,324 Added 28.93%
50,468 $2.66 Million
Q4 2017

Feb 01, 2018

BUY
$37.77 - $47.75 $669,511 - $846,416
17,726 Added 82.76%
39,144 $1.82 Million
Q3 2017

Oct 31, 2017

BUY
$34.14 - $40.45 $731,210 - $866,358
21,418
21,418 $866,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.